TY - JOUR
T1 - Staphylococcus aureus bacteremia, Australia
AU - Collignon, Peter
AU - Nimmo, Graeme R.
AU - Gottlieb, Thomas
AU - Gosbell, Iain B.
PY - 2005/4
Y1 - 2005/4
N2 - Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review wyas undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that ≈6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB.
AB - Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review wyas undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that ≈6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB.
UR - http://www.scopus.com/inward/record.url?scp=16244396420&partnerID=8YFLogxK
U2 - 10.3201/eid1104.040772
DO - 10.3201/eid1104.040772
M3 - Review article
AN - SCOPUS:16244396420
SN - 1080-6040
VL - 11
SP - 554
EP - 561
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 4
ER -
